Junji Shibata

711 total citations
22 papers, 577 citations indexed

About

Junji Shibata is a scholar working on Hepatology, Immunology and Virology. According to data from OpenAlex, Junji Shibata has authored 22 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 6 papers in Immunology and 5 papers in Virology. Recurrent topics in Junji Shibata's work include HIV Research and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Immune Cell Function and Interaction (5 papers). Junji Shibata is often cited by papers focused on HIV Research and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Immune Cell Function and Interaction (5 papers). Junji Shibata collaborates with scholars based in Japan and Georgia. Junji Shibata's co-authors include Shigetoshi Fujiyama, Shuzo Matsushita, Kazuhisa Yoshimura, Tatsuo Sato, Atsushi Koito, Masahiro Nakano, S Kishimoto, Shoji Fukushima, Terumasa Ikeda and Motohiko Tanaka and has published in prestigious journals such as The Journal of Immunology, Cancer and Journal of Virology.

In The Last Decade

Junji Shibata

21 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Shibata Japan 10 262 190 138 134 104 22 577
Wenge Xing China 14 262 1.0× 87 0.5× 193 1.4× 117 0.9× 51 0.5× 55 619
Kris Covens Belgium 8 113 0.4× 108 0.6× 148 1.1× 114 0.9× 95 0.9× 16 531
Shigehisa Mori Japan 13 243 0.9× 94 0.5× 247 1.8× 71 0.5× 105 1.0× 40 625
Nadia Alatrakchi United States 18 300 1.1× 366 1.9× 345 2.5× 270 2.0× 447 4.3× 27 1.1k
Abhay Patki United States 11 62 0.2× 219 1.2× 138 1.0× 129 1.0× 166 1.6× 18 729
Patricia Palladinetti Australia 9 261 1.0× 59 0.3× 228 1.7× 25 0.2× 202 1.9× 9 617
S. Erb Canada 10 64 0.2× 32 0.2× 136 1.0× 57 0.4× 64 0.6× 14 361
M. Bunce United Kingdom 16 67 0.3× 65 0.3× 178 1.3× 42 0.3× 594 5.7× 29 974
Jinxia Yao China 7 205 0.8× 176 0.9× 308 2.2× 65 0.5× 818 7.9× 9 1.1k
Karl‐H. Meyer zum Büschenfelde Germany 9 250 1.0× 31 0.2× 261 1.9× 42 0.3× 317 3.0× 14 676

Countries citing papers authored by Junji Shibata

Since Specialization
Citations

This map shows the geographic impact of Junji Shibata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Shibata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Shibata more than expected).

Fields of papers citing papers by Junji Shibata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Shibata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Shibata. The network helps show where Junji Shibata may publish in the future.

Co-authorship network of co-authors of Junji Shibata

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Shibata. A scholar is included among the top collaborators of Junji Shibata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Shibata. Junji Shibata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshimura, Kazuhisa, Shigeyoshi Harada, Junji Shibata, et al.. (2010). Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds. Journal of Virology. 84(15). 7558–7568. 66 indexed citations
2.
Ikeda, Terumasa, Junji Shibata, Kazuhisa Yoshimura, Atsushi Koito, & Shuzo Matsushita. (2007). Recurrent HIV‐1 Integration at theBACH2Locus in Resting CD4+T Cell Populations during Effective Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 195(5). 716–725. 94 indexed citations
3.
4.
Yoshimura, Kazuhisa, Junji Shibata, Tetsuya Kimura, et al.. (2006). Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS. 20(16). 2065–2073. 23 indexed citations
5.
Sakaguchi, Nobuo, Tetsuya Kimura, Shuzo Matsushita, et al.. (2005). Generation of High-Affinity Antibody against T Cell-Dependent Antigen in the Ganp Gene-Transgenic Mouse. The Journal of Immunology. 174(8). 4485–4494. 44 indexed citations
6.
Ikeda, Masafumi, Seishi Maeda, Junji Shibata, et al.. (2004). Transcatheter Arterial Chemotherapy with and without Embolization in Patients with Hepatocellular Carcinoma. Oncology. 66(1). 24–31. 74 indexed citations
7.
Maeda, Seishi, et al.. (2003). Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.. PubMed. 50(51). 809–13. 24 indexed citations
8.
Kinoshita, Hisafumi, Mitsuo Hashimoto, Satoshi Furukawa, et al.. (1999). A Case of Intraabdominal Bleeding Following Pancreatoduodenectomy Successfully Treated by Transcatheter Arterial Embolization.. The Kurume Medical Journal. 46(3/4). 191–194. 4 indexed citations
9.
Kinoshita, Hisafumi, et al.. (1996). A Case of Obstructive Icterus Caused by Incarceration of a Pancreatic Stone in the Common Channel of the Pancreatobiliary Ducts.. The Kurume Medical Journal. 43(1). 79–85. 5 indexed citations
10.
Fujiyama, Shigetoshi, et al.. (1995). Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver disease. Digestive Diseases and Sciences. 40(2). 457–464. 5 indexed citations
11.
Kinoshita, Hisafumi, et al.. (1995). Pancreatojejunal Sutural Insufficiency Occurring after Pancreatoduodenectomy and Countermeasures.. The Kurume Medical Journal. 42(4). 221–229. 4 indexed citations
12.
Fujiyama, Shigetoshi, Motohiko Tanaka, Masafumi Goto, et al.. (1995). Clinical evaluation of titration of hepatitis C virus core antibody and its subclasses. Journal of Gastroenterology and Hepatology. 10(3). 270–276. 7 indexed citations
13.
Tanaka, Motohiko, et al.. (1993). Vibrio vulnificus infection. With special reference to its clinical features and relationship with liver diseases.. Kanzo. 34(8). 643–648. 1 indexed citations
14.
Fujiyama, Shigetoshi, et al.. (1992). Two cases of chronic active hepatitis type C acommpanied with psychiatric symptoms during interferon therapy.. Kanzo. 33(1). 44–48. 2 indexed citations
15.
Shibata, Junji, Shigetoshi Fujiyama, Yoshikazu Honda‐Okubo, & Tatsuo Sato. (1992). Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis. Journal of Gastroenterology and Hepatology. 7(3). 277–282. 21 indexed citations
16.
17.
Fujiyama, Shigetoshi, et al.. (1991). Clinical usefulness of des-?-carboxy prothrombin assay in early diagnosis of hepatocellular carcinoma. Digestive Diseases and Sciences. 36(12). 1787–1792. 40 indexed citations
18.
Shibata, Junji, et al.. (1990). A prognostic evaluation of hepatic arterial injection chemotherapy with cisplatin suspended in Lipiodol for hepatocellular carcinoma.. Drug Delivery System. 5(1). 33–37. 2 indexed citations
19.
Shibata, Junji, Shigetoshi Fujiyama, Tatsuo Sato, et al.. (1989). Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer. 64(8). 1586–1594. 117 indexed citations
20.
Shibata, Junji, Shigetoshi Fujiyama, Tatsuo Sato, et al.. (1988). Intra-hepatic artery injectional chemotherapy with suspension of cisplatin in lipiodol for hepatocellular carcinoma.. Drug Delivery System. 3(3). 431–435. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenge Xing Breakdown of academic impact, for papers by Kris Covens Breakdown of academic impact, for papers by Shigehisa Mori Breakdown of academic impact, for papers by Nadia Alatrakchi Breakdown of academic impact, for papers by Abhay Patki Breakdown of academic impact, for papers by Patricia Palladinetti Breakdown of academic impact, for papers by S. Erb Breakdown of academic impact, for papers by M. Bunce Breakdown of academic impact, for papers by Jinxia Yao Breakdown of academic impact, for papers by Karl‐H. Meyer zum Büschenfelde
Rankless by CCL
2026